Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies

Br J Haematol. 2020 Jul;190(1):e16-e20. doi: 10.1111/bjh.16801. Epub 2020 May 27.
No abstract available

Keywords: acute respiratory distress syndrome; complete remission; coronavirus disease; haematological malignancies; interlerleukin 6.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Azithromycin / administration & dosage
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections* / blood
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / mortality
  • Coronavirus Infections* / therapy
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Hematologic Neoplasms* / blood
  • Hematologic Neoplasms* / diagnosis
  • Hematologic Neoplasms* / mortality
  • Hematologic Neoplasms* / therapy
  • Humans
  • Hydroxychloroquine / administration & dosage
  • Male
  • Middle Aged
  • Pandemics*
  • Pneumonia, Viral* / blood
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / mortality
  • Pneumonia, Viral* / therapy
  • Retrospective Studies
  • SARS-CoV-2
  • Survival Rate

Substances

  • Antibodies, Monoclonal, Humanized
  • Hydroxychloroquine
  • Azithromycin
  • tocilizumab